2006 Ed. Geistlich Söhne AG - Alle Rechte vorbehalten
english   deutsch  
About us    News    Contact    Partners/Distributors    Search    Sitemap
Geistlich Group

News

 

15 September 2009 -
Great interest in Geistlich Pharma AG at its Open Door Day

On 12.09.09, to mark the inauguration of the new office building Z5, Geistlich Pharma AG opened up to the public its new premises which were not yet occupied. This offer was gladly taken up by 400 curious visitors. A total of more than 1000 people came to the Open Door Day "D4 lives and laughs" last Saturday to get a look at the newly opened building in the D4 Business Center office complex.

The three business units of Geistlich Pharma AG (Biomaterials, Surgery and Medical) presented their activities and medical products. The Geistlich Pharma staff demonstrated which treatments their products are used for and answered the guests' numerous questions. Visitors were able to take a break for a reviving drink in the cafeteria or on the spacious terrace. A lot of people tried their luck and took part in the Geistlich Pharma competition where they could win a revitalising weekend for two. The winners have since been drawn and are being informed.

Over the weekend of 18 to 20 September, Geistlich Pharma AG is moving into its new premises in building Z5 as the last of the three main tenants. Until now, the regeneration experts have been located on three floors in another building at the D4 Business Center. From Monday all 70 staff at the Root site will be brought together on a single floor in the new building Z5. Another 150 employees work at the Wolhusen site, including the research and development departments.

In recent years Geistlich Pharma AG has grown continuously and has steadily invested in the central Swiss locations of Root and Wolhusen. The family-owned company relies on its highly qualified and specialised staff, whose number has steadily grown in the past. The move into the new premises is a sign of its growth and commitment to Central Switzerland as a location.

IMG_7793.jpgIMG_7806.jpgIMG_7816.jpgIMG_7844.jpgIMG_7867.jpg


15th December 2010
50 years – UK subsidiary celebrates its anniversary
Geistlich Sons Limited, the British subsidiary of Geistlich Pharma AG, celebrates its 50th anniversary in 2010 ...
» more

15.11.2010
PRESS RELEASE Dr. Terance Hart – the new Chief Scientific Officer in post for 100 days
The Board of Geistlich Pharma AG has had a full complement since 1st August 2010 with the appointment of Dr. Terance Hart as the Chief Scientific Officer (CSO).
» more

10th October 2010
EAO Conference in Glasgow: a resounding success!
This year's European Association for Osseointegration (EAO) conference took place in Glasgow from 7th – 9th October. As the gold sponsor, Geistlich Biomaterials was represented with a stand ...
» more

22 September 2010
250 days of the Geistlich Biomaterials Business Center at Inibsa!
Geistlich Pharma and Laboratorios Inibsa have been working together in a new structure in Spain for 250 days. An analysis of the first eight months has exceeded expectations.
» more

PRESS RELEASE 1 June 2010
New Brazilian subsidiary extends the Geistlich Pharma family
Geistlich Pharma AG has set up a subsidiary company in Brazil. From now on Geistlich biomaterials will be available directly on the largest South American market.
» more

27 May 2010
First German reference centre for cartilage regeneration named in Bochum
Geistlich Surgery named the Orthopaedic Department of the Catholic University Hospital Bochum (Katholisches Klinikum Bochum) as the first university reference centre for cartilage regeneration in Germany on 26 May...
» more

23. April 2010
Awarded: Alufoil Trophy 2010 for Aluminium Template
In April the European Aluminium Foil Association awarded the Alufoil Trophy 2010 to the Aluminium Template for trimming the Chondro-Gide® collagen matrix ...
» more

14 April 2010
Geistlich Pharma wins the 2010 Central Switzerland SVC Entrepreneur Prize
On 14th April Geistlich Pharma AG won the 2010 Central Switzerland Entrepreneur Prize awarded by the Swiss Venture Club (SVC) ...
» more

PRESS RELEASE: 16 March 2010
Geistlich Pharma buys the Walzmühle AG Wolhusen site
A sign of growth and investment in Central Switzerland ...
» more

23 December 2009
The Osteology Foundation grew internationally in 2009
The Osteology Foundation is developing more and more into an international institution in research and education ...
» more

16 December 2009
NEW: Geistlich Pharma at a glance
The new corporate flyer about Geistlich Pharma AG - online now ......
» more

13. Oktober 2009
High visitor numbers to Geistlich Symposium at EAO Congress 09
Geistlich Biomaterials catered for the high numbers attending with top-class speakers ...
» more

PRESS RELEASE: 21 September 2009
Geistlich Pharma AG occupies new premises
A sign of growth and investment in Central Switzerland ...
» more

10 September 2009
A warm welcome to Geistlich Pharma AG!
On 12 September, Geistlich Pharma AG is giving the public a glimpse behind the scenes of its future new place of work ...
» more

24. Juni 2009
Europerio, Stockholm – Geistlich Pharma on target
Geistlich Pharma AG showcased its business unit Geistlich Biomaterials at the 6th Europerio in Stockholm ...
» more

16. April 2009
IDS in Cologne 2009: Geistlich at Europe's biggest dental fair
With a prominent booth Geistlich Biomaterials took part in the 33rd International Dental Show (IDS) in Cologne from March 24th to 28th....
» more

05. March 2009
More room for quality
At the end of 2008 the Quality Assurance (QA) and Facility Maintenance & Development departments of Geistlich Pharma AG moved into their new premises...
» more

06. March 2009
Geistlich passes FDA inspection for the 5th time
In February 2009, Geistlich Pharma has fully passed the FDA-inspection. For the fifth time the company meets the strict criteria of the US Food and Drug Administration (FDA)....
» more

  © Geistlich Pharma AG
 Print page Recommend page Imprint Disclaimer Top